NXP Semiconductors (NASDAQ: NXPI ) has brought a new asset into its fold. The company announced it has acquired privately held Code Red Technologies. The latter, a provider of embedded software development tools, is seen as complementary to NXP Semi's existing business.
The terms of the deal were not made public.
NXP Semi said that Code Red's workforce will be consolidated across three locations; San Jose, Calif., Syracuse, N.Y., and Cambridge, U.K. At the moment, the latter has offices in Cambridge and San Francisco.
Hot Safest Stocks To Own For 2015: Guggenheim CurrencyShares Euro Trust (FXE)
Guggenheim CurrencyShares Euro Trust, formerly CurrencyShares Euro Trust, is a grantor trust. The Trust issues shares (the Shares) in blocks of 50,000 (a Basket) in exchange for deposits of euro and distributes euro in connection with the redemption of Baskets. The investment objective of the Trust is for the Shares to reflect the price of euro plus accrued interest. The Shares are intended to offer investors an opportunity to participate in the market for the euro through an investment in securities. The Shares are bought and sold on NYSE Arca. The Shares are backed by the assets of the Trust, which does not hold or use derivative products. The Trust holds euro and, from time to time, issues Baskets in exchange for deposits of euro and distributes euro in connection with redemptions of Baskets.
The Sponsor is Rydex Specialized Products LLC. The Bank of New York Mellon serves as the Trustee. JPMorgan Chase Bank, N.A., London Branch is the Depository. The Depository maintains two deposit accounts for the Trust, a primary deposit account which may earn interest and a secondary deposit account which does not earn interest (Deposit Accounts). The secondary deposit account is used to account for interest received and paid out on creations and redemptions of Baskets. The secondary account is also used to account for interest, if any, earned on the primary deposit account, pay Trust expenses and distribute any excess interest to Shareholders on a monthly basis.
Advisors' Opinion:- [By Richard Cox]
Elsewhere, similar market reactions could were seen after last week's monetary policy meeting at the European Central Bank [ECB]. The ECB also did little to signal changes to its own stimulus programs, which was not a total surprise, given the fact that the bank reduced interest rates by 25 basis points to new all-time lows at 0.75% at last month's meeting. The main potential for surprise, however, came from the possibility that the central bank would announce the implementation of negative interest rates (the rate paid to commercial banks when holding money). Since this would have been a bearish outcome for the EUR/USD, markets have since bought the Euro, pushing the CurrencyShares Euro Trust ETF (FXE) higher.
- [By Ben Levisohn]
The euro has dropped about 0.8% against the dollar, while the CurrencyShares Euro Trust ETF (FXE) has dropped 0.7% to $136.71 and the Currency Shares Japanese Yen Trust ETF (FXY) has fallen 1%. The ProShares UltrasShort Euro ETF (EUO) has gained 1.3% to $16.77, while the ProShares UltraShort Yen (YCS) has gained 1.9% to $66.58.
Top 10 Consumer Service Stocks For 2014: VALE S.A.(VALE)
Vale S.A. engages in the exploration, production, and sale of basic metals in Brazil. The company also involves in fertilizers, logistics, and steel businesses. The Bulk Material segment consist of iron ore mining and pellet production, as well as its Brazilian Northern and Southern transportation systems, including railroads, ports, and terminals. This segment also includes manganese mining and ferroalloys. The Base Metals segment produces nonferrous minerals, including nickel, copper, and aluminum consisting of aluminum trading activities, alumina refining, aluminum metal smelting, and bauxite mining. The Fertilizers segment provides potash, phosphates, and nitrogen. The Logistic Services segment consists of transportation systems, including ships, ports, and railroads for third party cargos. This segment includes 10,179 kilometers of railroad infrastructure, 8 seaport terminals, 5 general cargo ports, and 2 iron ore export terminals. In addition, it generates energy thr ough hydroelectric power plants. The company was founded in 1942 and is based in Rio de Janeiro, Brazil.
Advisors' Opinion:- [By Rich Duprey]
With Caterpillar's first-quarter GDP numbers coming in at an anemic 7.7% rate, significantly below analyst expectations of 8%, the unwinding of the Oriental growth story could plow under the company's potential. It's already taking down mining stocks, as shares of Vale� (NYSE: VALE ) have lost a quarter of their value since the start of the year, while Rio Tinto�is down 22%. BHP Billiton is only doing slightly better by losing just under 1% of its value.
Top 10 Consumer Service Stocks For 2014: Vectren Corporation (VVC)
Vectren Corporation, through its subsidiaries, provides energy delivery services to residential, commercial, and industrial and other contract customers in Indiana and west central Ohio. It offers natural gas distribution and transportation services, and electric distribution services; and owns and operates coal-fired and gas-fired electric generating facilities with an installed generating capacity of 1,298 megawatts. The company�s electric transmission system consists of 989 circuit miles of 345, 138, and 69 kilovolt lines, and 35 substations; and distribution system comprises 4,281 pole miles of lower voltage overhead lines and 372 trench miles of conduit containing 1,999 miles of underground distribution cable, 96 distribution substations, and 54,000 distribution transformers. In addition, it provides gas marketing, gas portfolio optimization, and other portfolio and energy management services to municipalities, utilities, industrial operations, schools, and healthcar e institutions; mines and sells coal; offers underground construction and repair, performance contracting, and renewable energy services; and invests in energy-related opportunities and services, real estate, and leveraged leases. Further, the company engages in transmission pipeline construction and maintenance; pump station, compressor station, terminal, and refinery construction; and hydrostatic testing services. It serves the automotive assembly, parts, and accessories; feed, flour, and grain processing; metal castings; aluminum products; polycarbonate resin and plastic products; gypsum products; electrical equipment; metal specialties; glass; steel finishing; pharmaceutical and nutritional products; gasoline and oil products; ethanol; and coal mining industries. As of December 31, 2011, it supplied natural gas services to approximately 993,300 customers; and electric services to approximately 141,600 customers. Vectren Corporation was founded in 1912 and is headquartere d in Evansville, Indiana.
Advisors' Opinion:- [By Lawrence Meyers]
I like the diversification, and the fact that the company has offered many of these products for anywhere from 30 years to 100 years may explain why it�� paid a dividend for the last 32 years. That dividend is presently at 4.3%.
Vectren Corporation (VVC)The final stock on our list of secret dividend stocks is Vectren Corporation (VVC). VVC is another an energy play that�� diversified into four segments. The company provides 566,000 customers with natural gas delivery in Indiana.
- [By Garrett Cook]
Utilities shares fell around 0.23 percent in trading on Wednesday. Top losers in the sector included Vectren (NYSE: VVC), down 1.9 percent, and Atmos Energy (NYSE: ATO), off 1 percent.
- [By Chuck Carnevale]
Vectren Corp. (VVC): A Low Growth Utility
Our first example looks at Vectren Corp.�� historical earnings, a utility with a 15-year historical earnings growth rate that is below our 3% threshold established in Part 1. Note that fair valuation is calculated using Graham Dodd�� Formula (GDF) deriving a fair value PE of 13.8 (slightly below, but close to our PE 15 standard). However, a normal PE of 16 has been historically applied by Mr. Market. Therefore, valuation falls between a PE of 13.8 to 16, or well within a range of normalcy.
- [By David Dittman]
Answer: I like NextEra Energy, which has significant renewables exposure and operates in a region with solid economic fundamentals. I also like smaller utes that operate in smaller footprints with solid long-term fundamentals, including Cleco (NYSE: CNL), Pinnacle West, Vectren (NYSE: VVC) and SCANA (NYSE: SCG).
Top 10 Consumer Service Stocks For 2014: Target Corporation(TGT)
Target Corporation operates general merchandise stores in the United States. The company offers household essentials, including pharmacy, beauty, personal care, baby care, cleaning, and paper products; hardlines comprising music, movies, books, computer software, sporting goods, and toys, as well as electronics that comprise video game hardware and software; apparel and accessories consisting of apparel for women, men, boys, girls, toddlers, infants, and newborns; and intimate apparel, jewelry, accessories, and shoes. It also provides food and pet supplies, including dry grocery, dairy, frozen food, beverages, candy, snacks, deli, bakery, meat, produce, and pet supplies; and home furnishings and d�or, such as furniture, lighting, kitchenware, small appliances, home d�or, bed and bath, home improvement, and automotive products, as well as seasonal merchandise, which include patio furniture and holiday d�or. The company sells its merchandise products under private-labe l and exclusive licensed brands. In addition, it provides in-store amenities. As of January 28, 2012, Target Corporation operated 1,763 stores in 49 states and the District of Columbia under Target and SuperTarget names. Further, it offers general merchandise through its Website, Target.com. The company distributes its merchandise through a network of distribution centers, as well as third parties and direct shipping from vendors. Additionally, it offers credit to guests through its branded proprietary credit cards, the Target Visa Credit Card and the Target Credit Card, as well as through its branded proprietary Target Debit Card. Target Corporation was founded in 1902 and is headquartered in Minneapolis, Minnesota.
Advisors' Opinion:- [By James Brumley]
Yes, Ron Johnson’s fame at Apple (AAPL) and Target (TGT) never translated into success at JCPenney (JCP), and in fact he steered the ship straight into the ground. However, JCP is (thankfully) at least trying “business as usual” again under Mike Ullman.
- [By Victor Reklaitis]
Today�� movers & shakers: Retailers have dropped in the wake of disappointing quarterly results or outlooks. Target Corp. (TGT) �was down 4% after posting weaker margins and earnings at its U.S. business, while Dollar Tree Inc. (DLTR) �dropped 4% after its earnings fell in the third quarter. Read more in the Movers & Shakers column.
- [By Anora Mahmudova]
Shares of Target Inc. (TGT) �fell 3.1% after announcing chief executive officer Gregg Steinhafel will resign immediately. Chief financial officer John Mulligan was named interim CEO.
- [By Ben Levisohn]
As you might have noticed, however, DiFrisco and Heng still like what Keurig has been able to do, including its deals with Target (TGT) and Coca-Cola (KO):
Top 10 Consumer Service Stocks For 2014: Air Products and Chemicals Inc. (APD)
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, performance materials, equipment, and services worldwide. The company?s Merchant Gases segment sells atmospheric gases, such as oxygen, nitrogen, and argon; process gases, including hydrogen and helium; and medical and specialty gases for the metal, glass, chemical processing, food processing, healthcare, steel, general manufacturing, and petroleum and natural gas industries. This segment also offers respiratory therapies, home medical equipment, and infusion services primarily in Europe. Its Tonnage Gases segment provides hydrogen, carbon monoxide, nitrogen, oxygen, and syngas to the energy production and refining, chemical, and metallurgical industries; and produces dinitrotoluene used in the manufacture of a precursor of polyurethane foam. The company?s Electronics and Performance Materials segment offers nitrogen trifluoride, silane, arsine, phosphine, white ammonia, silicon tetra fluoride, carbon tetrafluoride, hexafluoromethane, critical etch gases, and tungsten hexafluoride; and tonnage gases, specialty chemicals, and services and equipment for the manufacture of silicon and compound semiconductors, thin film transistor liquid crystal displays, and photovoltaic devices. This segment also provides performance materials for a range of products, including coatings, inks, adhesives, civil engineering, personal care, institutional and industrial cleaning, mining, oil refining, and polyurethanes. Its Equipment and Energy segment designs and manufactures cryogenic equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and helium distribution; and offers plant design, engineering, procurement, and construction management services for the chemical and petrochemical manufacturing, oil and gas recovery and processing, and steel and primary metals processing industries. The company was founded in 1940 and is based in All entown, Pennsylvania.
Advisors' Opinion:- [By Marshall Hargrave]
Icahn has been the talk of the activist circle of late, overshadowing some other notable activist campaigns. It appears that a combination of Ackman's own recent shortcomings and Icahn's high-profile Apple (Nasdaq: AAPL) investment has overshadowed Ackman's activist bet on the less-than-sexy industrial space. Since Ackman announced his 9.8% ownership of Air Products (NYSE: APD) at the end of July, the stock is relatively flat.
Top 10 Consumer Service Stocks For 2014: Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., incorporated on July 22, 1980, biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases. The Company�� product candidates include Eteplirsen, AVI-6002, AVI-6003, and AVI-7100. As of December 31, 2011, the Company primarily focused on advancing the development of its Duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen, which is in a Phase IIb trial. The Company is also focused on developing therapeutics for the treatment of infectious diseases, including its lead infectious disease programs aimed at the development of drug candidates for the Ebola and Marburg hemorrhagic fever viruses. The Company's program focuses on the development of disease-modifying therapeutic candidates for Duchenne muscular dystrophy (DMD). The Company initiated a Phase IIb trial for eteplirsen in August 2011 with an objective of initiating a pivotal trial subsequent to 2011.
The Company is also leveraging the capabilities of its RNA-based technology platforms to develop therapeutics for the treatment of infectious diseases. The Company's RNA-based drug programs are clinically evaluated for the treatment of DMD and have also demonstrated anti-viral activity in infectious diseases such as Ebola, Marburg and H1N1 influenza in certain animal models. The Company's lead product candidates are at various stages of development.
Duchenne Muscular Dystrophy Program
The Company's lead program is designed to address specific gene mutations that result in DMD by forcing the genetic machinery to skip over an adjacent contiguous piece of RNA and, thus, restore the ability of the cell to express a new, truncated but functional, dystrophin protein.
Eteplirsen is an antisense PMO-based therapeutic in clinical development for the treatment of individuals with DMD who have an error in the gene codi! ng for dystrophin that can be treated by skipping exon 51. Eteplirsen targets the frequent series of mutations that cause DMD. Eteplirsen has been granted orphan drug designation in the United States and European Union. In addition to the Company's lead product candidate, eteplirsen, the Company is actively pursues development of a product candidate that skips exon 45 through an IND-enabling collaboration.
Anti-Viral Programs
The Company is implementing its RNA-based technology platforms in its anti-viral programs for the development of therapeutics to treat viruses, such as Ebola, Marburg and influenza. The Company's arrangement with DoD supporting the development of the Company's Ebola and Marburg virus drug candidates provides funding for all clinical and licensure activities necessary to obtain approval of a New Drug Application (NDA), by the United States Food and Drug Administration (FDA), if DoD exercises all of its options under the arrangement. During the year ended December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and is exploring funding opportunities or partnerships with DHHS and industry collaborators to advance its development.
The Company's anti-viral therapeutic programs use the Company's translation suppression technology and applies its PMOplus chemistry backbone, an advanced generation of its base PMO chemistry backbone that selectively introduces positive backbone charges to improve selective interaction between the drug and its target. The Company's translation suppressing technology is based on Translation Suppressing Oligomers (TSOs), which are PMO-based compounds that stop or suppress the translation of a specific protein by binding to their specific target sequence in mRNA.
The Company is pursuing development and regulatory approval of its Ebola and Marburg hemorrhagic fever virus product candidates under the FDA's Animal Rule. The Company's lead product candidate against the Ebola virus infec! tion is A! VI-6002. For Marburg virus infection, the Company's lead product candidate has been AVI-6003. In February 2012, the Company announced that the Company received approval from the FDA to remove one of the two oligomers composing AVI-6003 and proceed with a single oligomer approach, AVI-7288, given that efficacy in non-human primates has been demonstrated to be attributable to this single oligomer. The Company is exploring the feasibility of alternate routes of administration of its Ebola and Marburg drug candidates, and at DoD's invitation, the Company is developing a proposal to be submitted for a study to demonstrates feasibility of the intramuscular route.
AVI-6002, which is a combination of AVI-7537 and AVI-7539, is designed for post-exposure prophylaxis after documented or suspected exposure to the Ebola virus. The Company is evaluating the feasibility of developing AVI-7537 as a single agent for the post-exposure prophylaxis after documented or suspected exposure to Ebola virus. AVI-6003, which is a combination of AVI-7287 and AVI-7288, is designed for post-exposure prophylaxis after documented or suspected exposure to Marburg virus. In February 2012, the Company announced that the Company received approval from the FDA to proceed with AVI-7288 as a single agent against Marburg virus infection. The Company intends to proceed with dosing AVI-7288 in the Phase I multiple ascending dose studies and in non-human primate studies.
Influenza Program
The Company's anti-viral therapeutic programs are also focused on the development of the Company's product candidates designed to treat pandemic influenza viruses. AVI-7100 is the Company's lead product candidate for the treatment of influenza and employs its PMOplus technology. In June 2011, the Company initiated dosing of AVI-7100 through intravenous infusion in single-ascending doses in up to 48 healthy adult volunteers. As of December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and are exp! loring fu! nding opportunities or partnerships to advance its development.
The Company has developed three new phosphorodiamidate-linked morpholino oligomers (PMO)-based chemistry platforms in addition to its original PMO-based technology. The Company's PMO-based molecules are designed to sterically block the access of cellular machinery to pre-mRNA and mRNA without degrading the RNA. Through this selective targeting, two distinct biologic mechanisms of action can be initiated: modulation of pre-mRNA splicing and inhibition of mRNA translation.
The Company competes with GlaxoSmithKline plc, Toyama Chemical, Alnylam Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corp., Isis Pharmaceuticals, Inc., Prosensa, and Santaris Pharma A/S.
Advisors' Opinion:- [By Keith Speights and Max Macaluso, Ph.D.]
Health care analyst Max Macaluso recently sat down with Fool contributor Keith Speights to talk about some of the best speculative biotech plays on the market. Max and Keith discussed three companies that investors should consider: Keryx Pharmaceuticals (NASDAQ: KERX ) , Sarepta Therapeutics (NASDAQ: SRPT ) , and MannKind (NASDAQ: MNKD ) .
- [By Selena Maranjian]
The biggest new holdings are Liberty Media�and the iShares MSCI Mexico Capped Investable Market Index Fund ETF. Other new holdings of interest include Sarepta Therapeutics (NASDAQ: SRPT ) . Sarepta stock has soared about ninefold over the past year, and some still see it as undervalued. After Sarepta petitioned the FDA for accelerated approval for its Duchenne muscular dystrophy drug, eteplirsen, the FDA requested more information. That sent shares lower, but management is optimistic about its recent interactions with the FDA.
Top 10 Consumer Service Stocks For 2014: Radware Ltd.(RDWR)
Radware Ltd. provides application delivery solutions and network security solutions to banks, insurance companies, manufacturing and retail, government agencies, media companies, and service providers worldwide. The company offers AppDirector Intelligent Application Delivery Controller for data center optimization and to eliminate traffic surges, server bottlenecks, connectivity disconnects, and downtime for business continuity; and Alteon Application Switch application delivery controller that supports local, global, and transparent load-balance, multi-homing network load-balance, and bandwidth management capabilities. It also provides AppXML, which offers XML and Web services communications for mission-critical applications; AppWall, a Web application firewall (WAF) appliance that secures Web applications; LinkProof that manages wide area networks and Internet traffic for networks; Content Inspection Director, a smart redirection and dynamic policy enforcement device to meet contemporary carrier needs; and Session Initiation Protocol Director, an application delivery controller for application vendors, telecom equipment manufacturers, and system integrators. In addition, the company offers DefensePro Intrusion Prevention and Denial of Service products that protect against worms, bots, viruses, malicious intrusions, and DOS attacks; Inflight, a hardware device that provides online and network-based monitoring solutions; and APSolute Vision, an appliance-based management and monitoring system for information technology staff to centrally manage distributed devices and check the performance and security of enterprise wide application delivery infrastructures. It markets and sells its products primarily through distributors and resellers in North America, Europe, and Asia, as well as directly to select customers in the United States. Radware Ltd. was founded in 1996 and is headquartered in Tel Aviv, Israel.
Advisors' Opinion:- [By Seth Jayson]
Radware (Nasdaq: RDWR ) reported earnings on July 25. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), Radware met expectations on revenues and missed estimates on earnings per share.
No comments:
Post a Comment